Galectin Therapeutics
Richard E. Uihlein co-founded Uline, Inc. (a leading distributor of shipping, packaging, and industrial supplies) in 1980, and has served as its Chief Executive Officer and Chairman since its founding. Prior to founding Uline Inc., Mr. Uihlein was employed at General Bindings Corp., Northbrook, IL from 1967 to 1980. Mr. Uihlein graduated from Stanford University, Palo Alto, California with a BA degree in history in 1967.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Galectin Therapeutics
1 followers
Galectin Therapeutics (NASDAQ: GALT) is applying its leadership in galectin science and drug development to create new therapies for fibrotic disease and cancer. Drug candidates based on the Company’s unique carbohydrate technology target galectin proteins which are key mediators of biologic and pathologic function.